Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Hongjiu Biotech is a prominent biotechnology company specializing in the research, cultivation, and production of standardized botanical extracts. Based in the Jilin province of China, the company is globally recognized for its expertise in ginseng-derived products, including Panax ginseng and American ginseng extracts. Their product portfolio features high-purity ginsenosides and other herbal derivatives used extensively in the pharmaceutical, nutraceutical, and functional food industries. The company operates GMP-certified manufacturing facilities and maintains rigorous quality control standards to serve a diverse international clientele. By leveraging local agricultural resources and advanced extraction technologies, Jilin Hongjiu Biotech provides comprehensive ingredient solutions for health and wellness applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Hongjiu Biotech.